CliniExperts Successfully Completes Phase IV Akynzeo® I.V Study for Glenmark
CliniExperts Research Services Pvt. Ltd
New Delhi [India], November 27: CliniExperts Research Services Pvt. Ltd., New Delhi, India, proudly announces the successful completion of Phase IV study on Akynzeo® I.V for Glenmark Pharmaceuticals Ltd. As a CRO, CliniExperts provided end-to-end Clinical Support, including Site Management and Clinical Operations support.
Study Title: An open-label, single-arm, multicenter, prospective study to evaluate the safety and effectiveness of Akynzeo® I.V. [Fosnetupitant 235 mg and Palonosetron 0.25 mg (concentrate for solution for infusion)], in the Prevention of chemotherapy-induced nausea and vomiting (CINV) in Indian patients (STOP-CINV study).
Study Design:
178 adult patients (male or female) aged ≥18 and ≤75 years, scheduled to receive their first cy...









